Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
AstraZeneca
McKesson
Colorcon
Express Scripts
Moodys

Last Updated: October 1, 2022

Litigation Details for Silvergate Pharmaceuticals, Inc. v. Bionpharma Inc. (D. Del. 2020)


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


Small Molecule Drugs cited in Silvergate Pharmaceuticals, Inc. v. Bionpharma Inc.
The small molecule drugs covered by the patents cited in this case are See Plans and Pricing , See Plans and Pricing , See Plans and Pricing , and See Plans and Pricing .
Biologic Drugs cited in Silvergate Pharmaceuticals, Inc. v. Bionpharma Inc.

Details for Silvergate Pharmaceuticals, Inc. v. Bionpharma Inc. (D. Del. 2020)

Date Filed Document No. Description Snippet Link To Document
2020-10-26 16 Redacted Document the ’745 Patent U.S. Patent No. 10,039,745 the ’987 Patent U.S. Patent No. 10,154,987 Original…regarding U.S. Patent Nos. 9,669,008 (the “’008 Patent”); 9,808,442 (the “’442 Patent”); 10,039,745 (the “’745…Application the ’008 Patent U.S. Patent No. 9,669,008 the ’442 Patent U.S. Patent No. 9,808,442 the…the ’868 patent U.S. Patent No. 10,772,868 New Patents The ’482 and ’868 patents, collectively… ’745 Patent / ’987 Patent ’868 Patent ’482 Patent Limitation External link to document
2021-04-05 74 Exhibits A-C .S. Patent No. 9,669,008, U.S. Patent No. 9,808,442, U.S. Patent No. 10,039,745, and U.S. Patent No.….S. Patent No. 9,669,008, U.S. Patent No. 9,808,442, U.S. Patent No. 10,039,745, and U.S. Patent No.….S. Patent No. 9,669,008, U.S. Patent No. 9,808,442, U.S. PatentNo. 10,039,745, and U.S. PatentNo. 10,154,987…U.S. Patent Application No. 15/802,341, filed November 2, 2017 (now U.S. Patent No. 10,039,745, issued…nonstatutory double patenting as being unpatentable over claims 1-20 of U.S. Patent No. 10,039,745, herein referred External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Moodys
McKinsey
Harvard Business School
Colorcon
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.